B. Beutler et Ge. Grau, TUMOR-NECROSIS-FACTOR IN THE PATHOGENESIS OF INFECTIOUS-DISEASES, Critical care medicine, 21(10), 1993, pp. 190000423-190000435
Objectives: To review the immunologic role of the cytokines and the sp
ecific role that tumor necrosis factor (TNF) plays in response to infe
ction. The influence of bacterial lipopolysaccharide on TNF, the cytok
ine cascade, and resultant pathologies are also reviewed. Data Sources
: A MEDLINE search of the international English language literature fr
om 1960 to the present was reviewed, but data from the past 5 Yrs prim
arily formed the basis for this review. Study Selection: Those studies
detailing the interaction of lipopolysaccharide, TNF, and other cytok
ines, and their roles in combating infection were emphasized. Investig
ations that described animal and human results served as the primary d
atabase. Data Extraction: Animal studies were selected based on the re
levance of the model to the pathogenesis of the human clinical syndrom
e. Where they provided supportive evidence, patient studies were selec
ted on the basis of study design.Data Synthesis: TNF plays a key role
in the normal immune response to infection, limiting the spread of pat
hogens. Exaggerated physiologic responses occur under the influence of
high concentrations of TNF that are released in response to overwhelm
ing infection, resulting in aberrations in coagulation, cell adhesion,
chemo-taxis/transmigration, and vascular integrity. These pathologic
effects may be inhibited by anti-TNF monoclonal antibodies and recombi
nant soluble receptor inhibitory proteins. Conclusions: TNF exerts bot
h physiologic and pathologic effects in response to infection; these e
vents may lead to organ dysfunction and death. Anti-TNF therapies appe
ar to attenuate the injurious effects of TNF.